15 Einträge gefunden

1. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
2. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

   1. Minner, Sarah
   2. Hager, Dominik
   3. Steurer, Stefan
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Möller-Koop, Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. SNW1 is a prognostic biomarker in prostate cancer

   1. Höflmayer, Doris
   2. Willich, Carla
   3. Hube-Magg, Claudia
   4. Simon, Ronald
   5. Lang, Dagmar
   6. Neubauer, Emily
   7. Jacobsen, Frank

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

   1. Kind, Simon
   2. Merenkow, Christina
   3. Büscheck, Franziska
   4. Möller, Katharina
   5. Dum, David
   6. Chirico, Viktoria
   7. Luebke, Andreas M

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

   1. Büscheck, Franziska
   2. Zub, Maciej
   3. Heumann, Asmus
   4. Hube-Magg, Claudia
   5. Simon, Ronald
   6. Lang, Dagmar S
   7. Höflmayer, Doris

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
6. Histological, epidemiological and anatomical analysis of 193 bone tumours of the scapula

   1. Priemel, Matthias H
   2. Erler, Johannes M E
   3. Zustin, Jozef
   4. Luebke, Andreas M
   5. Stiel, Norbert
   6. Spiro, Alexander S

   2019 - Forschungsinformationssystem des UKE
7. Prognostic and diagnostic role of PSA immunohistochemistry:A tissue microarray study on 21,000 normal and cancerous tissues

   1. Bonk, Sarah
   2. Kluth, Martina
   3. Hube-Magg, Claudia
   4. Polonski, Adam
   5. Soekeland, Greta
   6. Makropidi-Fraune, Georgia
   7. Möller-Koop, Christina

   2019 - Forschungsinformationssystem des UKE
8. Symptomatic Mandibular Fibrous Dysplasia With Concurrent Triple X- and Premutation Stage Fragile-X-Syndrome: Case Report With Short Literature Survey

   1. Friedrich, Reinhard E
   2. Kohlrusch, Felix K
   3. Luebke, Andreas M

   2019 - Forschungsinformationssystem des UKE
9. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

   1. Steurer, Stefan
   2. Hager, Benjamin
   3. Büscheck, Franziska
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Minner, Sarah
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
10. Bone tumours of the clavicle: Histopathological, anatomical and epidemiological analysis of 113 cases

    1. Priemel, Matthias H
    2. Stiel, Norbert
    3. Zustin, Jozef
    4. Luebke, Andreas M
    5. Schlickewei, Carsten
    6. Spiro, Alexander S

    2019 - Forschungsinformationssystem des UKE
11. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

    1. Weidemann, Sören A
    2. Sauer, Charlotte
    3. Luebke, Andreas M
    4. Möller-Koop, Christina
    5. Steurer, Stefan
    6. Hube-Magg, Claudia
    7. Büscheck, Franziska

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
12. A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

    1. Eichenauer, Till
    2. Hussein, Mohammad
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Büscheck, Franziska
    6. Höflmayer, Doris
    7. Tsourlakis, Maria Christina

    2019 - Forschungsinformationssystem des UKE
13. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    1. Steurer, Stefan
    2. Schwemmer, Lara
    3. Hube-Magg, Claudia
    4. Büscheck, Franziska
    5. Höflmayer, Doris
    6. Tsourlakis, Maria Christina
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE
14. 5q21 deletion is often heterogeneous in prostate cancer

    1. Kluth, Martina
    2. Al Kilani, Zaid
    3. Özden, Cansu
    4. Hussein, Khakan
    5. Frogh, Sohall
    6. Möller-Koop, Christina
    7. Burandt, Eike

    2019 - Forschungsinformationssystem des UKE
15. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

    1. Schroeder, Cornelia
    2. Navid-Hill, Elham
    3. Meiners, Jan
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Makrypidi-Fraune, Georgia
    7. Simon, Ronald

    2019 - Forschungsinformationssystem des UKE